#DealMonitor
+++ #DealMonitor +++ Healthcare group Fresenius invests in HealthTech Avelios Medical +++ HealthTech ViViRA raises capital +++ Financial injection for Onyx Biotech +++
In the #DealMonitor For May 7th we’ll take a look at the most important, exciting and interesting investments and exits of the day in the DACH region. All deals from the previous days are available in a large and clear format #DealMonitor Archives.
STARTUPLAND 2027: SAVE THE DATE
The next unicorn? You’ll meet it at STARTUPLAND
+++ Did you miss our phenomenal third STARTUPLAND? Then put our new date in your calendar now: The next STARTUPLAND will take place on March 10, 2027. More about Startupland
INVESTMENTS
Avelios Medical
+++ The medical technology and healthcare group Fresenius is investing an undisclosed sum in Avelios Medical. Most recently, the German software giant SAP invested in HealthTech. Fresenius and SAP announced a few months ago that they would like to work together to accelerate digital healthcare in Germany. Avelios Medical, founded in 2020 by Nicolas Jakob, Sebastian Krammer and Christian Albrecht, positions itself as a hospital information system. The aim is to “optimize clinical processes, reduce the documentation effort and intelligently network patient data – from admission to billing”. “Avelios consistently invests the capital in sustainable team building, with a focus on product and delivery structures, and increases operational clout for successfully scaling rollouts on an enterprise scale,” the companies said. Sequoia Capital and existing investors such as Revent and High-Tech Gründerfonds (HTGF) recently invested 30 million euros in the company. More about Avelios Medical
ViViRA
+++ The Berlin investor IBB Capital, the Munich impact investor Bonventure and TeleClinic founder Patrick Palacin are investing an undisclosed sum in ViViRA. The company based in Berlin and Munich, founded in 2015 by Philip Heimann, Petra Becker and Fabian Blank, develops digital health solutions (DTx/DiGA) in the musculoskeletal health segment. This includes, among other things, the topic of back pain. Bonventure and Spanish impact funder Ship2B Ventures previously invested in the company. More about ViViRA
Onyx Biotech
+++ The Göttingen Life Science Valley growth fund, Freiraum Ventures from Munich and business angels are investing in Onyx Biotech. The startup from Vaterstetten, founded in 2024 by the brothers Florian and Gregor Essert, develops “digital solutions to optimize process engineering processes in pharmaceuticals, biotech and chemistry”. The startup’s digital twins should be able to shorten development cycles from months to just a few days. More about Onyx Biotech
Startup jobs: Looking for a new challenge? In ours Job exchange You will find job advertisements from startups and companies.